Progress in preventive therapy for cancer: a reminiscence and personal viewpoint

Impact of a Panel of 88 Single Nucleotide Polymorphisms on the Risk of Breast Cancer in High-Risk Women: Results From Two Randomized Tamoxifen Prevention Trials

(2017) Jack Cuzick et al.   JOURNAL OF CLINICAL ONCOLOGY

Age-specific risks, severity, time course, and outcome of bleeding on long-term antiplatelet treatment after vascular events: a population-based cohort study

(2017) Linxin Li et al.   LANCET

Preventive therapy for cancer

(2017) Jack Cuzick   LANCET ONCOLOGY

Aspirin for the Prevention of Cancer Incidence and Mortality: Systematic Evidence Reviews for the U.S. Preventive Services Task Force

(2016) Jessica Chubak et al.   ANNALS OF INTERNAL MEDICINE

Breast cancer risk feedback to women in the UK NHS breast screening population

(2016) D Gareth R Evans et al.   BRITISH JOURNAL OF CANCER

ADD-ASPIRIN: A phase III, double-blind, placebo controlled, randomised trial assessing the effects of aspirin on disease recurrence and survival after primary therapy in common non-metastatic solid tumours

(2016) Christopher Coyle et al.   Contemporary Clinical Trials

The impact of a panel of 18 SNPs on breast cancer risk in women attending a UK familial screening clinic: a case–control study

(2016) D Gareth Evans et al.   JOURNAL OF MEDICAL GENETICS

Differing Perspectives on Breast Cancer Chemoprevention

(2016) Jack Cuzick et al.   JAMA Oncology

Factors affecting uptake and adherence to breast cancer chemoprevention: a systematic review and meta-analysis

(2015) S. G. Smith et al.   ANNALS OF ONCOLOGY

The Contributions of Breast Density and Common Genetic Variation to Breast Cancer Risk

(2015) Celine M. Vachon et al.   JNCI-Journal of the National Cancer Institute

Tamoxifen for prevention of breast cancer: extended long-term follow-up of the IBIS-I breast cancer prevention trial

(2015) Jack Cuzick et al.   LANCET ONCOLOGY

A 9-Valent HPV Vaccine against Infection and Intraepithelial Neoplasia in Women

(2015) Elmar A. Joura et al.   NEW ENGLAND JOURNAL OF MEDICINE

The Contributions of Breast Density and Common Genetic Variation to Breast Cancer Risk

(2015) Celine M. Vachon et al.   JNCI-Journal of the National Cancer Institute

Estimates of benefits and harms of prophylactic use of aspirin in the general population

(2014) J. Cuzick et al.   ANNALS OF ONCOLOGY

Uptake of tamoxifen in consecutive premenopausal women under surveillance in a high-risk breast cancer clinic

(2014) L S Donnelly et al.   BRITISH JOURNAL OF CANCER

Adjuvant tamoxifen-induced mammographic breast density reduction as a predictor for recurrence in estrogen receptor-positive premenopausal breast cancer patients

(2013) Kyung Lan Ko et al.   BREAST CANCER RESEARCH AND TREATMENT

Mammographic Density Reduction Is a Prognostic Marker of Response to Adjuvant Tamoxifen Therapy in Postmenopausal Patients With Breast Cancer

(2013) Jingmei Li et al.   JOURNAL OF CLINICAL ONCOLOGY

Selective oestrogen receptor modulators in prevention of breast cancer: an updated meta-analysis of individual participant data

(2013) Jack Cuzick et al.   LANCET

Anastrozole for prevention of breast cancer in high-risk postmenopausal women (IBIS-II): an international, double-blind, randomised placebo-controlled trial

(2013) Jack Cuzick et al.   LANCET

Aspirin and cancer risk: a quantitative review to 2011

(2012) C. Bosetti et al.   ANNALS OF ONCOLOGY

The role of aspirin in cancer prevention

(2012) Michael J. Thun et al.   Nature Reviews Clinical Oncology

Tamoxifen-Induced Reduction in Mammographic Density and Breast Cancer Risk Reduction: A Nested Case-Control Study

(2011) J. Cuzick et al.   JNCI-Journal of the National Cancer Institute

Exemestane for Breast-Cancer Prevention in Postmenopausal Women

(2011) Paul E. Goss et al.   NEW ENGLAND JOURNAL OF MEDICINE

The utility of Aspirin in dukes C and high risk dukes B colorectal cancer - The ASCOLT study: study protocol for a randomized controlled trial

(2011) Raghib Ali et al.   Trials

Update of the National Surgical Adjuvant Breast and Bowel Project Study of Tamoxifen and Raloxifene (STAR) P-2 Trial: Preventing Breast Cancer

(2010) V. G. Vogel et al.   Cancer Prevention Research

Long-term effect of aspirin on colorectal cancer incidence and mortality: 20-year follow-up of five randomised trials

(2010) Peter M Rothwell et al.   LANCET

Effect of daily aspirin on long-term risk of death due to cancer: analysis of individual patient data from randomised trials

(2010) Peter M Rothwell et al.   LANCET

Aspirin and non-steroidal anti-inflammatory drugs for cancer prevention: an international consensus statement

(2009) Jack Cuzick et al.   LANCET ONCOLOGY